Skip to main content
Equibles
IVF logo

IVF · INVO Fertility, Inc.

Track IVF — free

Use IVF with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.03 +0.02 (+1.98%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$2.53M
Shares
2.51M

IVF metrics

53 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.01
Market cap
$2.53M

Price action

19 metrics
Price change (1W)
-4.7%
Price change (30D)
+3.6%
Price change (3M)
-33.6%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
203.7%
Beta
0.5
RSI (14D)
44.9
Price vs SMA 50
-14.6%
Price vs SMA 200
—
Avg volume (3M)
4.19M
Relative volume
0.1
Average dollar volume
$7.99M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
2.51M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 358,464.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 297.4%
P / book
0.2
reciprocal yield 651.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
1,567.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-17

Profitability

9 metrics
Gross margin
—
Operating margin
-78.7%
Trailing 12 months
Net margin
527.1%
Gross profit (TTM)
$668,507
Operating profit (TTM)
−$5.93M
Net income (TTM)
$39.69M
Trailing 12 months
Diluted EPS (TTM)
$3,620.49
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1,048.49

Growth

11 metrics
Revenue growth YoY
+16.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$7.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+25,987.2%
Year over year · more shares
Revenue CAGR (3Y)
+102.6%
Revenue CAGR (5Y)
+45.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
240.7%
Return on assets
153.7%
Debt / equity
0.1
Current ratio
0.7
EBITDA (TTM)
−$5.37M
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
-6.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.96M
Total assets
$25.83M
Total debt
$1.64M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.77M
Capital expenditures (TTM)
$43,412
R&D (TTM)
—
SG&A (TTM)
$8.02M
Stock compensation (TTM)
$1.23M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
10
13F filer change QoQ
+2
Institutional ownership
5.2%

Short interest

3 metrics
Short interest
9.1%
Latest settlement · 4.1 days to cover
Days to cover
4.1d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1417926 CUSIP 44984F880 13F (30d) 11 filings 11 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)